ONCO Stock Analysis: Buy, Sell, or Hold?
ONCO - Onconetix, Inc. Common Stock
$1.94
-1.28 (-39.75%)
▼
5d:
+212.9%
30d:
+193.94%
90d:
+25.97%
SELL
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 11, 2026
Get Alerted When ONCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⚠️ CAUTION: ONCO is extended with warning signals. Consider taking profits or waiting for better entry.
⚠️ CAUTION: ONCO is extended with warning signals. Consider taking profits or waiting for better entry.
In-depth Analysis How we analyze
Valuation Analysis: ONCO is currently trading at $1.94, which is considered extended relative to its 30-day fair value range of $0.17 to $1.51.
Technical Outlook: Technically, ONCO is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $6.73. Short-term momentum is weak, with the stock down 39.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+363.9%). Given the valuation headwinds and technical position, caution is warranted at these levels.
Technical Outlook: Technically, ONCO is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $6.73. Short-term momentum is weak, with the stock down 39.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+363.9%). Given the valuation headwinds and technical position, caution is warranted at these levels.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.17 -
$1.51
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
30.0%
All Signals
- BEARISH: Price significantly overextended (+28.5% above fair value)
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-39.8%)
- BULLISH: Trading 363.9% below Wall St target ($9.00)
Fair Price Analysis
30-Day Fair Range
$0.17 -
$1.51
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.45
Resistance Level
$6.73
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Wall Street Target
$9.00
(+363.9%)
Revenue Growth (YoY)
-57.4%
Share & Embed Analysis
Last updated: March 30, 2026 8:31 AM ET
Data refreshes hourly during market hours. Next update: 9:31 AM
Data refreshes hourly during market hours. Next update: 9:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCO showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 60 BUY |
